Alcon AG | ALC - Cost Of Sales

Stock Price
59.48
Daily Change
-0.42 -0.70%
Monthly
-7.47%
Yearly
-26.37%
Q1 Forecast
59.31

Alcon AG reported $1.2B in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
AstraZeneca USD 3.27B 471M Dec/2025
Bayer EUR 4.5B 194M Dec/2025
Essilor EUR 6.06B 741M Dec/2025
Fresenius EUR 4.45B 262M Dec/2025
Fresenius Medical Care EUR 3.68B 38.37M Dec/2025
GlaxoSmithKline GBP 2.61B 377M Dec/2025
GRIFOLS EUR 1.29B 163.12M Dec/2025
Lonza CHF 2.28B 189M Jun/2025
Merck EUR 2.29B 183M Dec/2025
Novartis USD 3.54B 3M Dec/2025
Philips EUR 2.81B 417M Dec/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
Sanofi EUR 4.29B 421M Dec/2025
Smith & Nephew USD 870M 17M Dec/2025
Sonova Holding CHF 539.4M 11.5M Dec/2025
UCB EUR 901M 50M Dec/2024